Institute of Medical Equipment, Academy of Military Medical Sciences, Tianjin, 300161, People's Republic of China.
J Mater Sci Mater Med. 2010 May;21(5):1751-9. doi: 10.1007/s10856-010-3996-6. Epub 2010 Jan 26.
This study investigated the characteristics and drug release properties of membranes of chitosan and alginate prepared via a casting/solvent evaporation technique. Membranes of chitosan and alginate with silver sulfadiazine as model drug incorporated in different concentrations and different membrane compositions were obtained. The polyblend solution viscosity reached to the highest at the composition polyblends of (1:1). This chitosan/alginate membranes showed pH- and ionic strength-dependent water uptake properties and had the WVTR rang from 442 to 618 g/m(2)/day. The maximum value of the dry membrane of breaking strength was 52.16 MPa and the maximum value of the wet membrane breaking elongation was 46.28%. The results of controlled release studies showed that the silver sulfadiazine release rate was the fastest when the alginate content was 50%. On the basis of the requisite physical properties, the chitosan-alginate PEC membrane can be considered for potential wound dressing or controlled release application.
本研究采用浇铸/溶剂蒸发技术研究了壳聚糖和海藻酸钠膜的特性和药物释放性能。以磺胺嘧啶银为模型药物,通过不同浓度和不同膜组成制备了壳聚糖和海藻酸钠膜。当共混溶液的组成为(1:1)时,共混溶液的粘度达到最高。壳聚糖/海藻酸钠膜具有 pH 值和离子强度依赖性的水分吸收特性,水蒸气透过率(WVTR)范围为 442 至 618 g/m(2)/天。干膜断裂强度的最大值为 52.16 MPa,湿膜断裂伸长率的最大值为 46.28%。控制释放研究结果表明,当海藻酸钠含量为 50%时,磺胺嘧啶银的释放速度最快。基于所需的物理性能,壳聚糖-海藻酸钠 PEC 膜可用于潜在的伤口敷料或控制释放应用。